Εμφανίζονται 1 - 12 Αποτελέσματα από 12 για την αναζήτηση '"идиопатическая фокальная эпилепсия"', χρόνος αναζήτησης: 0,60δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal

    Συγγραφείς: G. G. Toropina, Г. Г. Торопина

    Πηγή: Meditsinskiy sovet = Medical Council; № 10 (2017); 60-64 ; Медицинский Совет; № 10 (2017); 60-64 ; 2658-5790 ; 2079-701X ; 10.21518/2079-701X-2017-10

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.med-sovet.pro/jour/article/view/1868/1807; Löscher W, Hönack D. Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur. J. Pharmacol., 1993, 232: 147-158.; Gower AJ, Hirsch E, Boehrer A, Noyer M, Marescaux C. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res, 1995, 22: 207-213.; Klitgaard H, Matagne A, Gobert J, Wülfert E. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur. J. Pharmacol., 1998, 353: 191-206.; Noyer M, Gillard M, Matagne A, Hénichart JP, Wülfert E. The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes. Eur. J. Pharmacol., 1995, 286: 137-146.; Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc. Natl. Acad. Sci. USA, 2004, 101: 9861-9866.; Lukyanetz EA, Shkryl VM, Kostyuk PG. Selective blockade of N-type calcium channels by levetiracetam. Epilepsia, 2002, 43: 9-18.; Rigo JM, Hans G, Nguyen L, Rocher V, Belachew S, Malgrange B, Leprince P, Moonen G, Selak I, Matagne A, Klitgaard H. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABAand glycine-gated currents. Br. J. Pharmacol., 2002, 136: 659-672.; Niespodziany I, Klitgaard H, Margineanu DG. Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices. Neurosci. Lett., 2001, 306: 5-8.; Glass GA, Stankiewicz J, Mithoefer A, Freeman R, Bergethon PR. Levetiracetam for seizures after liver transplantation. Neurology, 2005, 64: 1084-1085.; Zaatreh MM. Levetiracetam in porphyric status epilepticus: a case report. Clin. Neuropharmacol., 2005, 28: 243-244.; Brockmöller J, Thomsen T, Wittstock M, Coupez R, Lochs H, Roots I. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests. Clin. Pharmacol. Ther., 2005, 77: 529-541.; Зенков Л.Р. Кеппра в лечении эпилепсии. М.: Пресс-сервис, 2007.; Abou-Khalil B.W. Levetiracetam Efficacy in Idiopathic Generalized Epilepsy: Long Suspected and Now Confirmed in Randomized Clinical Trials. Epilepsy Curr., 2008, 8: 16-18.; Verrotti A, Cerminara C, Coppola G, Franzoni E, Parisi P, Iannetti P, Aloisi P, Tozzi E, Cusmai R, Vigevano F, Chiarelli F, Curatolo P. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. Dev. Med. Child. Neurol., 2008, 50: 29-32.; Alhamrani М, Babtain F, Bhatia H, Velmurugan M. Comparison of Levetiracetam With Sodium Valproate in Controlling Seizure in Patients Suffering From Juvenile Myoclonic Epilepsy. Jentashapir. J. Health Res, 2014, 5(4): e21875.; Sirven JI, Drazkowski JF. Levetiracetam. Wyllie’s Treatment of Epilepsy: Principles and Practice (5th ed). Eds.: Wyllie E, Cascino GD, Gidal BE, Goodkin HP. Phyladelphia: Lippincott Williams & Wilkins, 2011: 731-735.; Карлов В.А., Власов П.Н., Жидкова И.А. Предварительные результаты эффективности генерического леветирацетама (эпитерра) в тонотерапии эпилепсии у взрослых пациентов. Неврология, нейропсихиатрия, психосоматика, 2015, спецвыпуск 1: 36-40.; Vrielynck P. Current and emerging treatments for absence seizures in young patients. Neuropsychiatr. Dis. Treat., 2013, 9: 963-975.; Trinka E, Dobesberger J. New treatment options in status epilepticus: a critical review on intravenous levetiracetam. Ther. Adv. Neurol. Dis., 2009, 2: 79-91.; Atmaca MM, Orhan EK, Bebek N, Gurses C. Intravenous levetiracetam treatment in status epilepticus: A prospective study. Epilepsy Res, 2015, 114: 13-22.; Grosso S, Cordelli DM, Franzoni E, Coppola G, Capovilla G, Zamponi N, Verrotti A, Morgese G, Balestri P. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy. Seizure, 2007, 16: 345-350.; Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J. Levetiracetam: safety and efficacy in neonatal seizures. Eur. J. Paediatr. Neurol., 2011, 15: 1-7.; Mruk AL, Garlitz KL, Leung NR. Levetiracetam in neonatal seizures: A Review. J. Pediatr. Pharmacol. Ther., 2015, 20: 76-89.; Mawhinney E, Craig J, Morrow J, Russell A, Smithson WH, Parsons L, Morrison PJ, Liggan B, Irwin B, Delanty N, Hunt SJ. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. Neurology, 2013, 80: 400-405.; Anderson P. Lamotrigine, Levetiracetam top AEDs in pregnancy. American Epilepsy Society (AES) 2016 Annual Meeting. Poster 1.211, December, 2016.; Johannessen SI, Helde G, Brodtkorb E. Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia, 2005, 46: 775-777.; Werhahn KJ, Klimpe S, Balkaya S, Trinka E, Krämer G. The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: A one-year observational study. Seizure, 2011, 20: 305-311.

  2. 2
    Academic Journal

    Συγγραφείς: Mukhin K.Y., Pylaeva O.A., Mironov M.B.

    Πηγή: Russian Journal of Child Neurology; Vol 8, No 1 (2013); 3-12 ; Русский журнал детской неврологии; Vol 8, No 1 (2013); 3-12 ; 2412-9178 ; 2073-8803

    Περιγραφή αρχείου: application/pdf

  3. 3
    Academic Journal
  4. 4
    Academic Journal

    Συγγραφείς: Mukhin K.Y.

    Πηγή: Russian Journal of Child Neurology; Vol 10, No 3 (2015); 7-14 ; Русский журнал детской неврологии; Vol 10, No 3 (2015); 7-14 ; 2412-9178 ; 2073-8803

    Περιγραφή αρχείου: application/pdf

  5. 5
    Academic Journal

    Πηγή: Russian Journal of Child Neurology; Том 9, № 1 (2014); 58-60 ; Русский журнал детской неврологии; Том 9, № 1 (2014); 58-60 ; 2412-9178 ; 2073-8803 ; 10.17650/2073-8803-2014-9-1

    Περιγραφή αρχείου: application/pdf

    Relation: https://rjdn.abvpress.ru/jour/article/view/13/9; Карлов В.А., Овнатанов Б.С. Медиобазальные эпилептические очаги и абсансная активность на ЭЭГ. Журн невропатол психиатр 1987:87(6):805–12.; Мухин К.Ю. Идиопатическая фокальная эпилепсия с псевдогенерализованными приступами – особая форма эпилепсии в детском возрасте. Рус журн дет неврол 2009;4(2):3–19.; Мухин К.Ю., Миронов М.Б., Тысячина М.Д. и др. Электро-клиническая характеристика больных симптоматической фокальной эпилепсией с феноменом вторичной билатеральной синхронизации на ЭЭГ. Рус журн дет неврол 2006;1(1):6–17.; https://rjdn.abvpress.ru/jour/article/view/13

  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12